General Information of the Compound
| Compound ID |
CP0570795
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
N-[(3R)-1-[3-(3,4-dimethoxyphenyl)-2-methylimidazo[1,2-b]pyridazin-8-yl]pyrrolidin-3-yl]acetamide
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C21H25N5O3
|
||||||||||||||||||
| Molecular Weight |
395.463
|
||||||||||||||||||
| Canonical SMILES |
COc1ccc(cc1OC)-c1c(C)nc2c(ccnn12)N1CC[C@H](C1)NC(C)=O
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C21H25N5O3/c1-13-20(15-5-6-18(28-3)19(11-15)29-4)26-21(23-13)17(7-9-22-26)25-10-8-16(12-25)24-14(2)27/h5-7,9,11,16H,8,10,12H2,1-4H3,(H,24,27)/t16-/m1/s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
OGNCVDCZXXFLIH-MRXNPFEDSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound